Synodex Revenue and Competitors
Estimated Revenue & Valuation
- Synodex's estimated annual revenue is currently $808k per year.
- Synodex's estimated revenue per employee is $101,000
Employee Data
- Synodex has 8 Employees.
- Synodex grew their employee count by 0% last year.
Synodex's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Customer Relations | Reveal Email/Phone |
2 | Director Technology Infrastructure | Reveal Email/Phone |
3 | Business Development Executive | Reveal Email/Phone |
4 | Client Engagement/Project Management | Reveal Email/Phone |
5 | Research Specialist | Reveal Email/Phone |
Synodex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 9 | -31% | N/A | N/A |
#2 | $18.6M | 92 | 24% | N/A | N/A |
#3 | $0.8M | 8 | -58% | N/A | N/A |
#4 | $0.7M | 7 | 0% | N/A | N/A |
#5 | $3.4M | 24 | -11% | N/A | N/A |
#6 | $0.7M | 7 | -22% | N/A | N/A |
#7 | $0.6M | 6 | 0% | N/A | N/A |
#8 | $1.3M | 11 | -54% | N/A | N/A |
#9 | $1.7M | 14 | 8% | N/A | N/A |
#10 | $10.5M | 58 | 18% | N/A | N/A |
What Is Synodex?
Synodex offers the ability to unlock the contents of paper and imaged medical documents and turn them into usable information, data which can be integrated into an organization's systems or used to create easy to read reports. Our goal is to assist organizations, which rely on medical records, save expert time, be more efficient and make more accurate decisions. Together with our partner/owner, Innodata Inc., we offer access to world-class document technology and over 6,000 high-end production staff at 10 worldwide locations.
keywords:N/AN/A
Total Funding
8
Number of Employees
$808k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.6M | 8 | 0% | N/A |
#2 | $1M | 8 | -27% | N/A |
#3 | $0.6M | 8 | 0% | N/A |
#4 | $0.7M | 9 | -10% | N/A |
#5 | $0.9M | 10 | 11% | N/A |